Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01006239 · ClinicalTrials.gov registry record
The Biorepository for Scripps Health
A clinical trial of Cancer, sponsored by Scripps Translational Science Institute.
- Active
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT01006239: Active study of Cancer, sponsored by Scripps Translational Science Institute.
NCT01006239 is a study of Cancer that is active but no longer recruiting, run by Scripps Translational Science Institute. The registered enrollment target is 10,000 participants, above the 3,475-participant average among 615 other Cancer trials with a reported enrollment target (188% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01006239, a study of Cancer, is active but no longer recruiting, sponsored by Scripps Translational Science Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose to establish a Biorepository of both diseased and normal tissue collected from subjects undergoing surgery for solid tumor resection. In cooperation with the Scripps Cancer registry, the investigators will also establish an anonymized database of corresponding clinical information including response to treatment, disease status, and recurrence. The Biorepository for Scripps Health will be able to process, preserve, and distribute samples to scientific and medical researchers at Scripps.
Primary Outcome
Establish a Biorepository of both diseased and normal tissue
Conditions Studied
Interventions
- OTHER No study intervention
Study Locations (1)
California
- Scripps Mercy Hospital - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2009-11 |
| Est. Completion | 2030-01 |
What the registry record for NCT01006239 still lists
NCT01006239 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 3,475-participant average among 615 other Cancer trials with a reported enrollment target (188% higher).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which No study intervention is the first listed.
NCT01006239 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01006239 about?
NCT01006239 is a clinical study titled "The Biorepository for Scripps Health". The investigators propose to establish a Biorepository of both diseased and normal tissue collected from subjects undergoing surgery for solid tumor resection. In cooperation with the Scripps Cancer registry, the investigators will also establish an anonymized database of corresponding clinical info...
What is the current status of trial NCT01006239?
This trial is currently active not recruiting. The enrollment target is 10,000 participants. The study started on 2009-11. Estimated completion is 2030-01.
What conditions does trial NCT01006239 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT01006239?
The interventions under investigation include: No study intervention (OTHER).
Who is sponsoring clinical trial NCT01006239?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01006239 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01006239's enrollment target sits among peer trials
10,000 23rd of 615 higher than 584 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
- NCT01000883 · 10,000 participants
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia